| 000 | 01883 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513193704.0 | ||
| 264 | 0 | _c19991119 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/(sici)1097-0215(19991126)83:5<650::aid-ijc14>3.0.co;2-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHochegger, K | |
| 245 | 0 | 0 |
_aProtein-kinase-C iso-enzymes support DNA synthesis and cell survival in colorectal-tumor cells. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cNov 1999 |
||
| 300 |
_a650-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine _xanalogs & derivatives |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aCarcinogens _xpharmacology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xphysiology |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xbiosynthesis |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHT29 Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMembrane Proteins _xmetabolism |
| 650 | 0 | 4 |
_aNaphthalenes _xpharmacology |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 650 | 0 | 4 | _abcl-2 Homologous Antagonist-Killer Protein |
| 700 | 1 | _aPartik, G | |
| 700 | 1 | _aSchörkhuber, M | |
| 700 | 1 | _aMarian, B | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 83 _gno. 5 _gp. 650-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0215(19991126)83:5<650::aid-ijc14>3.0.co;2-7 _zAvailable from publisher's website |
| 999 |
_c10478798 _d10478798 |
||